Product
NEXI-001 T Cells
Aliases
Infusion of NEXI-001 T Cells
1 clinical trial
2 indications
Indication
Acute Myeloid LeukemiaIndication
Myelodysplastic SyndromeClinical trial
A Phase 1 / 2 Study to Evaluate the Safety, Tolerability and Initial Anti-Tumor Activity of Adoptively Transferred T Lymphocytes Targeting WT1, PRAME and Cyclin A1 AML or MDS Patients With Relapsed Disease After Matched Allogeneic HCTStatus: Active (not recruiting), Estimated PCD: 2024-10-01